Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report AXS-05 (dextromethorphan/bupropion) targets agitation in Alzheimer's disease. Explore the FDA regulatory landscape, patent filings, and key competitors including brexpiprazole.
Article | Report A 2026 patent and literature landscape of space debris removal technology: capture systems, laser ablation, drag augmentation, SSA, and emerging ISRU paradigms.
Article | Report BMS's Cobenfy (xanomeline-trospium) targets Alzheimer's disease psychosis in ADEPT Phase III, with H2 2026 readout set to challenge pimavanserin's contested hold on the market.
Article | Report How AI is transforming the way materials engineers search for and evaluate substitutes during critical raw material supply disruptions. Explore the tools and frameworks reshaping industrial resilience.
Article | Report A 2026 landscape of in-memory analog computing: RRAM, PCM, flash-based neural memory, and NV-CAM patents mapped across key assignees and emerging directions.
Article | Report Imetelstat Phase III data in low-risk MDS: transfusion independence outcomes, Geron/J&J trial results, and competitive positioning against luspatercept.
Article | Report How engineers manage EMC between high-power wireless charging systems and vehicle electronics — standards, shielding strategies, and IP research tools explained.
Article | Report A 2026 landscape of epigenome editing technology: CRISPR/dCas9 platforms, key innovators, patent trends, and therapeutic applications — without altering DNA sequence.
Article | Report How AI-assisted computer vision improves dimensional measurement accuracy in high-speed automated assembly lines — technology landscape, methods, and industry implications.
Article | Report Pfizer's marstacimab anti-TFPI antibody enters Phase III for hemophilia A and B. How does it stack up against emicizumab and fitusiran in the non-factor race?
Article | Report A 2026 landscape of collaborative robot safety technology: collision detection, SSM, sensor fusion, cybersecurity co-assurance, and emerging IP signals across 15+ countries.
Article | Report A 2026 patent and literature landscape of molten salt reactor fuel processing: fluoride/chloride salt formulation, pyrochemical reprocessing, and spent LWR fuel conversion.
Article | Report Novo Nordisk's Mim8 bispecific antibody targets FIXa and FX to challenge Hemlibra in hemophilia A. Explore the clinical, IP, and competitive landscape ahead of the FDA decision.
Article | Report No patent or literature data was available to support this article. Learn how to expand your search for deep space radiation qualification research using PatSnap Eureka.
Article | Report How cerebral organoid maturation is evolving in 2026: vascularization breakthroughs, bioreactor engineering, epigenetic benchmarking, and the IP landscape mapped.